# Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

> **NCT01724671** · — · UNKNOWN · sponsor: **CPL Associates** · enrollment: 30 (estimated)

## Conditions studied

- MRSA Infection
- Bacteremia
- ABSSSI
- Pneumonia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01724671
- **Lead sponsor:** CPL Associates
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01724671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01724671, "Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01724671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*